Chugai Pharma
USA inherits a rich R&D-oriented heritage begun in 1925 by its
parent company, Chugai, in Tokyo. With more than 20% of net sales
invested in R&D, the pharmaceutical firm continues to contribute
significant safe and effective ethical drugs to promote well being
around the globe.
